Pharmacology of agents used for the treatment of common joint problems Flashcards

1
Q

What are the three key inflammatory mediators targeted by anti-inflammatory drugs?

A

Eicosanoids (e.g., prostaglandins, thromboxanes)

Biological oxidants

Cytokines
🧠 Mnemonic: “Eat Bright Carrots” (Eicosanoids, Biological oxidants, Cytokines).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which COX isoform is primarily involved in inflammatory prostaglandin synthesis?

A

COX-2 (cyclooxygenase-2).
🖼️ Dominant in inflammation; NSAIDs inhibit COX-2 to reduce pain/swelling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain the mechanism of action of NSAIDs in treating inflammation.

A

NSAIDs block COX-2, inhibiting prostaglandin/thromboxane synthesis. This reduces:

Vasodilation

Vascular permeability

Pain signaling

Leukocyte migration
🧠 “No COX-2 → No PGs → No Inflammation!”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What initiates the inflammatory process?

A

Cellular damage from stimuli like infection, physical stress, autoimmune reactions, or chemicals. This activates transcription factors (e.g., NF-κB) that trigger inflammatory mediator release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are common adverse effects of NSAIDs?

A

GI ulcers/bleeding (reduced protective PGs)

Kidney damage (impaired renal blood flow)

Increased cardiovascular risk (e.g., with COX-2 inhibitors)

Allergic reactions (e.g., aspirin-induced asthma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications for NSAID use?

A

Peptic ulcer disease

Severe kidney/liver disease

Aspirin allergy (avoid salicylates)

Pregnancy (3rd trimester: risk of premature ductus arteriosus closure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications for NSAIDs in joint disorders?

A

Osteoarthritis pain

Rheumatoid arthritis inflammation

Acute gout flares

Ankylosing spondylitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Trade vs. generic names of NSAIDs: Examples?

A

Ibuprofen: Advil, Motrin

Celecoxib: Celebrex

Aspirin: Bayer, Ecotrin

Naproxen: Aleve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the three classifications of NSAIDs based on COX selectivity?

A

Non-selective COX-1/COX-2 inhibitors (e.g., ibuprofen, diclofenac)

Selective COX-2 inhibitors (e.g., celecoxib, rofecoxib)

Salicylates (e.g., aspirin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why do COX-2 inhibitors cause fewer gastrointestinal (GI) adverse effects than non-selective NSAIDs?

A

COX-2 inhibitors spare COX-1, which maintains protective prostaglandins (PGE₂) in the stomach lining.
🧠 “COX-2 spares COX-1 → Happy Stomach!”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the mechanism of diclofenac-induced gastric ulceration and how to mitigate it.

A

Cause: Diclofenac inhibits COX-1, reducing PGE₂ (protects gastric mucosa).

Prevention: Combine with omeprazole (PPI) or misoprostol (PG analog) to reduce acid/ulcer risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is ibuprofen not recommended with aspirin for cardioprotection?

A

Ibuprofen competes with aspirin for COX-1 binding, blocking aspirin’s irreversible antiplatelet effect.
🧠 “Ibuprofen blocks aspirin’s heart shield!”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse renal effects of NSAIDs (e.g., COX-2 inhibitors)?

A

Reduced renal blood flow (inhibits vasodilatory PGs).

Sodium retention → hypertension.

Risk of acute kidney injury (especially in volume-depleted patients).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Key uses of indomethacin?

A

Acute gout (rapid pain/inflammation relief).

Rheumatoid arthritis.
🖼️ High potency but limited by frequent side effects (e.g., headache, GI issues).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is aspirin contraindicated in gout?

A

Aspirin impairs uric acid excretion by inhibiting renal tubular secretion, worsening hyperuricemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Advantages and disadvantages of celecoxib (COX-2 inhibitor)?

A

Advantages: Fewer GI ulcers, no antiplatelet effect (safer for bleeding risk).

Disadvantages: No cardioprotection, expensive, risk of hypertension/edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What makes acetaminophen different from other NSAIDs?

A

Weak anti-inflammatory activity.

No COX inhibition in peripheral tissues (works centrally).

Safe for GI but risky in overdose (hepatotoxicity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does aspirin’s antiplatelet effect last 8–10 days?

A

Aspirin irreversibly inhibits COX-1 in platelets. Platelets lack nuclei to regenerate COX.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Formulations of NSAIDs?

A

Oral (tablets, capsules).

Topical (diclofenac gel).

Injectable (ketorolac).

Suppository (indomethacin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Trade vs. generic names:

Celecoxib

Ibuprofen

Diclofenac

A

Celecoxib → Celebrex

Ibuprofen → Advil, Motrin

Diclofenac → Voltaren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are rheumatic diseases?

A

Chronic inflammatory disorders (e.g., rheumatoid arthritis, systemic lupus erythematosus) characterized by immune-mediated tissue damage and increased phagocyte activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the primary goals of rheumatic disease management?

A

Relieve pain/symptoms.

Arrest disease progression.

Maintain mobility/quality of life.
🧠 “Relieve, Arrest, Maintain!”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Therapeutic strategies for rheumatic diseases?

A

Symptom control: NSAIDs, corticosteroids.

Disease modification: DMARDs (e.g., methotrexate, TNF-α inhibitors).
🖼️ NSAIDs = quick relief; DMARDs = long-term control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are DMARDs?

A

Disease-Modifying Antirheumatic Drugs (e.g., methotrexate, sulfasalazine) that slow/stop immune-mediated joint damage (no direct anti-inflammatory/analgesic effects).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why are corticosteroids not first-line for rheumatic diseases?

A

Long-term use causes severe adverse effects (osteoporosis, hyperglycemia, immunosuppression). Used short-term for acute flares.

26
Q

Key DMARD categories and examples?

A

Immunosuppressants: Methotrexate, cyclosporine.

Cytokine inhibitors: TNF-α blockers (etanercept), IL-1 antagonists (anakinra).

Others: Hydroxychloroquine, sulfasalazine.

27
Q

Second-line DMARDs?

A

Less commonly used due to toxicity (e.g., gold salts, penicillamine, cyclophosphamide).

28
Q

How do TNF-α inhibitors (e.g., infliximab) work?

A

Block TNF-α (pro-inflammatory cytokine), reducing joint inflammation/damage.
🖼️ “Neutralize TNF → Save the Joints!”

29
Q

Methotrexate in rheumatic disease: Mechanism and key risk?

A

Mechanism: Inhibits folate metabolism → suppresses T-cell/B-cell proliferation.

Risk: Hepatotoxicity, bone marrow suppression (requires folate supplementation).

30
Q

What is gout?

A

Arthropathy caused by monosodium urate crystal deposition in joints (often due to hyperuricemia).

31
Q

Acute gout treatment options?

A

NSAIDs (indomethacin).

Colchicine (inhibits neutrophil migration).

Corticosteroids (prednisone).

32
Q

Colchicine mechanism?

A

Inhibits microtubule polymerization → blocks neutrophil chemotaxis and inflammatory mediator release.
🧠 “Stop microtubules → Stop inflammation!”

33
Q

Trade vs. generic names:

Etanercept

Infliximab

Anakinra

A

Etanercept → Enbrel

Infliximab → Remicade

Anakinra → Kineret

34
Q

Why are DMARDs started early in rheumatoid arthritis?

A

Joint damage occurs within 18 months of symptom onset; early use slows irreversible damage.

35
Q

Hydroxychloroquine use and risk?

A

Use: Mild rheumatoid arthritis, lupus.

Risk: Retinal toxicity (requires annual eye exams).

36
Q

What is gout?

A

Gout is an arthropathy caused by monosodium urate crystal deposition in joints, leading to inflammation and pain, often due to hyperuricemia.

37
Q

Acute gout treatment options and their key considerations.

A

NSAIDs (e.g., indomethacin, diclofenac): Avoid aspirin (↑ uric acid).

Colchicine: Inhibits neutrophil migration; use low-dose (1.2 mg + 0.6 mg after 1 hr).

Corticosteroids: For NSAID/colchicine contraindications (e.g., prednisone, intra-articular injections).
🖼️ “Acute = Stop Inflammation Fast!”

38
Q

Colchicine mechanism of action?

A

Inhibits microtubule polymerization → blocks neutrophil chemotaxis and phagocytosis.
🧠 “No Microtubules → No Neutrophils!”

39
Q

What are the two primary causes of hyperuricemia?

A

Overproduction of uric acid.

Underexcretion of uric acid.
🧠 Mnemonic: “Produce or Excrete?”

40
Q

Why is aspirin avoided in gout management?

A

Aspirin inhibits uric acid excretion (↑ hyperuricemia) and may worsen acute attacks.

41
Q

Long-term gout management strategies.

A

Xanthine oxidase inhibitors: Allopurinol (adjust for renal impairment), febuxostat.

Uricosurics: Probenecid (↑ uric acid excretion; avoid in renal stones).

Combination therapy: Lesinurad + allopurinol for refractory cases.

Uricase analogs: Pegloticase (reserved for severe, refractory gout).

42
Q

Allopurinol key points.

A

Mechanism: Inhibits xanthine oxidase → ↓ uric acid production.

ADR: Rash, hepatotoxicity (monitor LFTs).

Contraindication: Hypersensitivity.

43
Q

When is pegloticase used?

A

For refractory gout unresponsive to xanthine oxidase inhibitors.
🖼️ Risk: Anaphylaxis (contraindicated in G6PD deficiency).

44
Q

Lesinurad (Zurampic) mechanism and use

A

Mechanism: Blocks URAT1/OAT4 transporters → ↑ uric acid excretion.

Use: Combined with xanthine oxidase inhibitors for inadequate response.

45
Q

Trade vs. generic names:
Allopurinol

Febuxostat

Pegloticase

A

Allopurinol → Zyloprim

Febuxostat → Uloric

Pegloticase → Krystexxa

46
Q

What is the target serum uric acid level in long-term gout management?

A

<6 mg/dL to prevent crystal formation and recurrent attacks.

47
Q

Probenecid limitations.

A

Avoid in renal impairment (CrCl <50 mL/min), renal stones, or overproducers.

Alkalinize urine to ↓ stone risk.

48
Q

Why do urate-lowering therapies initially trigger gout flares?

A

Rapid changes in uric acid levels destabilize tissue deposits → crystal shedding → inflammation.
🧠 “Start Low, Go Slow!”

48
Q

Febuxostat vs. allopurinol.

A

Febuxostat: Non-purine analog, no dose adjustment in mild-moderate renal impairment.

Allopurinol: Purine analog, requires renal dose adjustment.

49
Q

Corticosteroids in acute gout.

A

Use: Oral (prednisone), IM, or intra-articular (triamcinolone).

Avoid long-term: Risk of osteoporosis, hyperglycemia, immunosuppression.